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Abstract
Correct formation of disulfide bonds is critical for protein folding. We find that cells lacking protein disulfide
isomerases (PDIs) can use alternative mechanisms for correct disulfide bond formation. By linking correct
disulfide bond formation to antibiotic resistance, we selected mutants that catalyze correct disulfide formation in
the absence of DsbC, Escherichia coli’s PDI. Most of our mutants massively overproduce the disulfide oxidase
DsbA and change its redox status. They enhance DsbA’s ability to directly form the correct disulfides by
increasing the level of mixed disulfides between DsbA and substrate proteins. One mutant operates via a
different mechanism; it contains mutations in DsbB and CpxR that alter the redox environment of the periplasm
and increases the level of the chaperone/protease DegP, allowing DsbA to gain disulfide isomerase ability
in vivo. Thus, given the proper expression level, redox status, and chaperone assistance, the oxidase DsbA can
readily function in vivo to catalyze the folding of proteins with complex disulfide bond connectivities. Our
selection reveals versatile strategies for correct disulfide formation in vivo. Remarkably, our evolution of new
pathways for correct disulfide bond formation in E. coli mimics eukaryotic PDI, a highly abundant partially
reduced protein with chaperone activity. Antioxid. Redox Signal. 14, 2399–2412.
Introduction
Disulfide bonds act to stabilize many protein structures(8). The stability of disulfide-rich miniproteins, for in-
stance, is almost entirely dependent upon disulfide bonds (9).
Although disulfide bonds are important for folding and sta-
bility, their accurate formation is difficult to achieve. This is
particularly true for proteins with high levels of disulfide
connectivity, because the number of possible incorrect dis-
ulfides grows factorially as the number of cysteine residues
increases. In the eukaryotic endoplasmic reticulum, protein
disulfide isomerase (PDI), a thioredoxin fold protein, is
thought to be a key player in establishing both the initial ox-
idation state of protein thiols and in establishing proper
connectivity (20). PDI may be aided in these tasks by other
thioredoxin-related proteins present in the endoplasmic re-
ticulum and by the reduced glutathione (GSH)/oxidized GSH
(GSSG) redox buffer (16, 20). Thus, in eukaryotic organisms,
the pathways responsible for the initial oxidation of disulfides
and their proofreading or isomerization are thought to be
substantially intermingled.
In contrast, in the bacteria Escherichia coli, it has long been
thought that the disulfide oxidation and disulfide error cor-
rection systems are separate entities (14, 41). DsbA efficiently
oxidizes substrates cotranslocationally by forming disulfides
between cysteines that are adjacent in the amino acid se-
quence (consecutive disulfides) (6, 25). DsbA is then reox-
idized by the membrane bound protein DsbB (4, 5). DsbA has
very little proofreading or disulfide isomerase activity (43).
Proteins with nonconsecutive disulfides are thought to re-
quire the action of the E. coli disulfide isomerase, DsbC, to
correct mistaken disulfide linkages formed by DsbA (14). To
attack incorrect disulfides, DsbC must be kept in a reduced
form. This function is performed by the membrane protein
DsbD, which in turn is kept reduced by the cytosolic thior-
edoxin, a thioredoxin-reductase and NADPH-dependent
system (26, 28). DsbC may correct errors in disulfide forma-
tion via two principal mechanisms, a reductive mechanism
and a direct isomerase mechanism (18, 37). Both mechanisms
share a key step in which the reduced isomerase attacks in-
correct disulfides, resulting in the formation of a mixed dis-
ulfide between the isomerase and the substrate protein.
Although it has previously been suggested that DsbG, a
protein related to DsbC, may assist in the isomerization of
disulfide bonds as well, DsbG has almost no isomerization
activity in vitro (22). Instead, it now appears that DsbG is
involved in detoxifying sulfenic acid formation (13). Thus,
DsbC appears to be the predominant disulfide isomerase
present in E. coli, although it has been reported that DsbA has
significant isomerase activity in vivo in that it is able to cor-
rectly express RNaseI a protein that contains one nonconsec-
utive disulfide bond (30).
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To generate a selection system that allows us to directly link
correct disulfide bond formation to bacterial antibiotic resis-
tance, we engineered an additional nonconsecutive disulfide
into the ampicillin-resistance protein b-lactamase. This strategy
opened up the possibility of selecting for E. coli variants that
could catalyze disulfide bond isomerization in the absence of
DsbC. The selected mutants were capable of efficiently ex-
pressing a variety of proteins with multiple disulfide contain-
ing proteins in an E. coli strain that lacks DsbC. All but one of
these dsbC bypass mutants act by massively overproducing
DsbA, which apparently increases the level of mixed disulfides
formed between DsbA and substrate proteins. Higher levels of
mixed disulfides may in turn allow cells to directly perform
correct oxidation of multidisulfide containing substrates. The
remaining dsbC bypass mutant that we identified contains
mutations in both dsbB and cpxR, which act to alter the peri-
plasmic chaperone and redox environment and thus favor
disulfide isomerization. These results show that by direct se-
lection, we can easily direct the evolution of multiple alterna-
tive mechanisms for correct disulfide formation in vivo.
Materials and Methods
Strains and growth conditions
Strains and plasmids used in the study are listed in Table 1.
Unless otherwise noted, cultures were grown at 37C in LB
medium supplemented with appropriate antibiotics. The
knockout strains were generated through P1 transduction
from the Keio collection stock. A dsbB1-148 truncation was
generated by cam cassette insertion immediately after posi-
tion G148 using theWannermethod (12) in RGP209. Then, the
cam cassette was removed by pCP20 plasmid to obtain strain
RGP1079. RGP1126 was generated by moving the cpxR56 al-
lele from UVC56 to RGP1079 by P1 transduction using
kdgT::kan as a selection marker from the Keio collection of
knockouts (3). Thus, RGP1126 is the reconstituted strain
containing the two only essential mutations fromUVC56. The
kan cassette was then removed by pCP20 plasmid to obtain
strain RGP1146.
Plasmid construction and site-directed mutagenesis
Point mutations were introduced into the wild-type bla
gene in pBR322 using a Stratagene Quick Change kit (Stra-
tagene) and appropriate mutagenic primers, and polymerase
chain reaction was performed as directed. The product was
digested withDpnI, precipitated using Pelletpaint according
to the protocol supplied by the manufacturer (Novagen)
(DpnI), and resuspended in *10lL ddH2O. Five microliters
of product was transformed into TG1 competent cells (Stra-
tagene). DNA was extracted from the cells and all point mu-
tations were verified by DNA sequencing. Single disulfide
bond b-lactamasemutants weremade using a similar strategy
but with multiple rounds of the procedure. Overexpression of
DsbA was achieved by inserting the dsbA gene into pBAD33
with restriction sites XbaI and HindIII. The MBP-bovine
pancreatic trypsin inhibitor (BPTI) fusion protein was con-
structed by inserting a codon optimized BPTI after the MBP
protein in the pMal-p2 (NEB) vector with the restriction sites
SalI and HindIII. Then, the tobacco etch virus protease rec-
ognition site of ENLYFQS was immediately inserted before
the BPTI sequence.
Mutagenesis, screening, and mapping of mutants
suppressing the dsbC - ampicillin phenotype
RGP209 harboring pBR322 plasmid (R209 hereafter) was
mutagenized with UV light. UV-irradiated cells were plated to
nonselection (Tet) or selection (with 1.5 g/L ampicillin) plates
and grown overnight at 37C. Colonies appearing on the selec-
tion plates were screened on LB plates with 50lM cadmium to
remove the loss-of-function mutants (broken disulfide bond
formation machinery also suppresses the dsbC- null strain
phenotype as indicated in Fig. 1C). Colonies surviving the cad-
mium screen were restreaked to LB plates containing 1.5 g/L
ampicillin and subsequently to Tet plates. Suppressor candi-
dates were then collected for further tests to rule out other false-
positive possibilities. Plasmids from the colonies were extracted
and sequenced to guarantee no mutation in the bla gene. Poly-
merase chain reaction validation of the dsbC- deletion in the
genome was done to confirm no environmental bacterial con-
tamination. Linkage of the mutations to the dsbA loci was tested
by P1 transduction using a yihG::Kan strain from the Keio col-
lection. To move the dsbA loci region of UVC49, the yigZ::Kan
strain from the Keio collection was used as selection for P1
transduction. The dsbA gene of each mutant was amplifiedwith
two primers 100bp upstream or downstream of dsbA and sub-
jected to sequence analysis. For suppressor strain UVC56, dsbB
and dsbD genes were also amplified with primers 100 bp up-
stream and downstream, respectively, and subjected to se-
quence analysis. Tomap the othermutations in the genome,we
carried out genome sequencing using an Illumina (‘‘Solexa’’)
Genome Analyzer II. The genomic library was prepared ac-
cording to Dr. Dave Lazinski, Tufts University. Of the 298 se-
quences tested, differenceswere observed between ER1821 and
UVC56. Five candidate genes (yhjA, dsbB, dsbG, pqiA, and cpxR)
were further examined because they mapped to genes that link
to envelopeproteins potentially involved in protein folding.We
checked these candidate genes by P1 transduction of both the
wild-type genes and the knockout of these genes into UVC56.
Spot titers for ampicillin resistance, cadmium
resistance, and copper resistance
Spot titers for ampicillin resistance were performed to test
the b-lactamase or PDI detector b-lactamase activity in vivo.
Cadmium resistance was performed to quantify the relative
disulfide oxidase activity of the strains in vivo. Spot titers for
copper resistance were performed to quantify the relative
isomerase or reductase activity in vivo as described. Briefly,
strains were grown overnight in LB and diluted 1:100 into
fresh LB media with appropriate antibiotics. Strains were
grown to mid-logarithmic phase at 37C and serially diluted
into 150mMNaCl. A 2 lL aliquot of each dilution was plated
onto LB plates with an ampicillin or cadmium gradient, or
were plated onto terrific broth plates with 15–17mM CuCl2.
Cells were grown at 37C overnight. All spot titers were
performed at least in triplicate.
Urokinase and BPTI activity assays
Urokinase assays were performed on strains transformed
with plasmid pRDB8-A, which expresses mouse urokinase
plasminogen activator constitutively as described in Rietsch
et al. (33). Periplasmic extract of bacteria grown to exponential
phase was separated on nonreducing sodium dodecyl sulfate
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Table 1. Strains and Plasmids Used in This Study
Strain name Genotype/insert Notes
ER1821 (wild type) F - glnV44 e14 - (McrA - ) rfbD1? relA1? endA1 spoT1? thi-1 D(mcrC-mrr)114::IS10 New England Biolabs
RGP209 ER1821 dsbC- Lab stock
RGP433 ER1821 dsbC- dsbB - Lab stock
RGP663 ER1821+ pPDI detector This study
RGP664 ER1821 dsbA - + pPDI detector This study
RGP665 RGP209 + pPDI detector (the starting strain) This study
RGP666 ER1821 dsbD - + pPDI detector This study
RGP667 ER1821 dsbA - dsbC- + pPDI detector This study
RGP668 ER1821 trxA- + pPDI detector This study
RGP669 ER1821 trxB- + pPDI detector This study
RGP181 ER1821+pBR322 This study
RGP188 ER1821 dsbA - +pBR322 This study
RGP195 ER1821 dsbC- +pBR322 This study
RGP286 ER1821 dsbD - +pBR322 This study
RGP202 ER1821 dsbA - dsbC- +pBR322 This study
RGP655 ER1821+ pBla 81-108 This study
RGP685 ER1821+ pBla 52-81 This study
RGP686 ER1821+ pBla 98-108 This study
RGP719 ER1821+ pBla 52-108 This study
RGP720 ER1821+ pBla 81-98 This study
RGP829/834 UVC49/54, dsbC - suppressor strains This study
RGP843/848 UVC56/61, dsbC - suppressor strains This study
RGP852 UVC62, dsbC- suppressor strains This study
RGP877/880 UVC63/66, dsbC - suppressor strains This study
RGP849 UVC49 cured the pBR322 plasmid This study
RGP851 UVC52 cured the pBR322 plasmid This study
RGP1079 ER1821 dsbB1-148 dsbC- (dsbB was truncated as in UVC56) This study
RGP1126 ER1821 dsbB1-148dsbC - cpxRM23I,E24K(kdgT::kan) This study
RGP1146 RGP1126 kan cassette removed This study
RGP929 RGP433 +pPDI detector This study
RGP982 RGP1079 + pPDI detector This study
RGP916 UVC56 dsbA - This study
RGP917 UVC56 dsbB - This study
RGP918 UVC56 dsbD - This study
RGP919 UVC56 dsbG - This study
RGP920 UVC56 umuD::kan (dsbB +) This study
RGP1073 UVC56 kdgT::kan (cpxR +) This study
RGP1071 UVC56 umuD - (dsbB +) kdgT::kan (cpxR +) This study
RGP1181 ER1821+ pRDB8-a This study
RGP1182 RGP209 + pRDB8-a This study
RGP1183 UVC49 + pRDB8-a This study
RGP1184 UVC52 + pRDB8-a This study
RGP1185 RGP1126 + pRDB8-a This study
RGP1244 RGP209 + pRDB8-a +pBADDsbA This study
RGP1246 RGP1079 + pBADDsbA This study
RGP860 ER1821+pMPB This study
RGP862 RGP209 +pMPB This study
RGP856 UVC49 +pMPB This study
RGP858 UVC52 +pMPB This study
RGP1130 RGP1126 +pMPB This study
RGP1256 UVC56 degP - This study
RGP1269 RGP665 yigZ::kan49 (dsbA loci from UVC49) This study
Plasmid name
pBR322 With wild-type b-lactamase (Bla) in the vector Lab stock
pPDI detector pBR322, Bla with mutations of S81C (TCA to TGT) and T108C (ACT to TGT) This study
pBla 81-108 pBR322 with Bla C52S C98S S81C T108C This study
pBla 52-81 pBR322 with Bla C98S S81C This study
pBla 98-108 pBR322 with Bla C52S T108C This study
pBla 81-98 pBR322 with Bla C52S S81C This study
pRDB8-a Urokinase constitutively active in the periplasm Lab stock
pMPB MBP and BPTI fusion protein in the periplasm This study
pETDsbA Codon optimized DsbA sequence Lab stock
pBADDsbA DsbA expression induced by arabinose This study
BPTI, bovine pancreatic trypsin inhibitor; MBP, maltose binding protein.
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FIG. 1. Design and charac-
teristics of a protein dis-
ulfide isomerase (PDI)
detector b-lactamase con-
struct that links correct dis-
ulfide bond formation to
bacterial antibiotic resis-
tance. (A) Model structure of
the TEM1 b-lactamase PDI
detector construct containing
an engineered disulfide gen-
erated by cysteine substitu-
tions at both serine 81 and
threonine 108; model is based
on the wild-type crystal
structure (PDB = 1BTL). (B)
Possible patterns of disulfide
bond linkage within the PDI
detector b-lactamase. The
native disulfide bond in b-
lactamase is C52-C98. A na-
tive-like disulfide C81-C108
was engineered so as not to
substantially disrupt the na-
tive structure. The native-like
pattern (iii) is active (circled in
green), whereas formation of
other disulfides (ii and iv)
inactivates b-lactamase (Fig.
2). Fully reduced PDI detec-
tor b-lactamase (i) is also ex-
pected to be active. (C) PDI
detector b-lactamase exhibits decreased antibiotic resistance in Escherichia coli mutants that are deficient in disulfide isom-
erization. Mutants lacking any known component of the disulfide isomerization pathway, namely, thioredoxin reductase
(trxB - ), thioredoxin (trxA - ), DsbD (dsbD - ), or DsbC (dsbC - ), decrease the ampicillin resistance of strains containing the PDI
detector. As expected from the full activity of reduced b-lactamase, strains containing the dsbA - mutation including dsbA -
and dsbA - dsbC -are ampicillin resistant. Spot titrations were performed on LB plates containing 1 g/L ampicillin (Amp) for
various strains transformed with the PDI detector construct in RGP663 (wild type), RGP664 (dsbA- ), RGP665 (dsbC - ),
RGP666 (dsbD - ), RGP667 (dsbA - dsbC - ), RGP668 (trxA - ), and RGP668 (trxB- ). (D) Analysis of the in vivo oxidation status of
PDI detector b-lactamase by 4-acetamido-4¢-maleimidylstilbene-2,2¢-disulfonic acid (AMS) trapping. The PDI detector is
oxidized in the wild-type strain, reduced in dsbA- and dsbA -dsbC - strains, and oxidized in dsbC - , dsbD - , trxA- , and trxB -
strains. (E) Addition of 1mM of the reductant DTT restores the growth of PDI detector b - lactamase in dsbC - and dsbD -
strains on media containing 1 g/L ampicillin. DTT, dithiothreitol. (To see this illustration in color the reader is referred to the
web version of this article at www.liebertonline.com/ars).
FIG. 2. The C52-C98 or C81-C108 disulfides are the only ones that allow b-lactamase to retain activity. (A) In vivo activity
of one disulfide bond containing b-lactamase mutants. The Western blot after acid-AMS-trapping at the far left shows the
expression level and redox status (all oxidized) of each variant as measured from whole cells using b-lactamase antibody. The
schemes in the middle indicate the names and linkages of the one disulfide bonded b-lactamase variants (engineered
cysteines are shown in red; wild-type cysteines are shown in black). The spot titer panel at the right shows their ampicillin
(0.2 g/L) resistance. The single disulfide bonded variants showed decreased ampicillin resistance compared to wild-type b-
lactamase. (B) A wild-type strain containing wild-type b-lactamase (52-98) (RGP181) grew well in liquid media containing
0.2 g/L ampicillin in the presence or absence of DTT (upper graph), whereas b-lactamase (C81-C108) (RGP655) grew some-
what in 0.2 g/L ampicillin, but only in the absence of DTT (lower graph). (C) 1mM DTT restores the ability of wild-type E. coli
strains containing b-lactamase C52-C81 (RGP685) (upper graph) or b-lactamase C98-C108 (RGP686) (lower graph) to grow on
media containing 0.2 g/L ampicillin. (D) 1mM DTT also restores the ability of wild-type strains containing b-lactamase C52-
C108 (RGP719) (upper graph) or b-lactamase C81-C98 (RGP720) (lower graph) to grow in media containing 0.2 g/L ampicillin.
The requirement of disulfide bond catalysis machinery for b-lactamase activity. (E) Cell-titer curves for strains expressing PDI
detector b-lactamase based on the spot titer assay on ampicillin gradient plates. Shown are wild type (RGP663), dsbA -
(RGP664), dsbC- (RGP665), dsbD - (RGP666), dsbA - dsbC- (RGP667), and trxA- (RGP668). (F) Cell-titer curves for strains
expressing wild-type b-lactamase based on the spot titer assay on ampicillin gradient plates. Shown are wild type (RGP181),
dsbA - (RGP188), dsbC - (RGP195), dsbD - (RGP286), and dsbA - dsbC - (RGP202). (To see this illustration in color the reader is
referred to the web version of this article at www.liebertonline.com/ars).
‰
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(SDS)–polyacrylamide gel electrophoresis gels, and urokinase
activity was demonstrated by assaying plasminogen activa-
tion by using plasminogen-casein agar. BPTI activity was
analyzed by testing residual trypsin activity (according to the
manufacturer Sigma-Aldrich instructions). A 50lL peri-
plasmic extract was used for a trypsin inhibition assay in a
1mL reaction using N-a-Benzoyl-L-arginine-4-nitranilide
(Roche) as the substrate. About 0.5 lg commercial BPTI was
used as a positive control, and a periplasmic extract of cells
expressing an empty vector was used as a negative control.
Motility assay
M9 media supplemented with 0.4% (v/v) glycerol as car-
bon source and free amino acids (40mg/L each) except cys-
teine was used to prepare 0.15% (w/v) minimal media
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motility agar plates. Plates containing cystine and GSSG were
also made by supplementing the above with 0.83mM cystine
and 0.83mM GSSG, respectively. A single colony of the
starting strain was inoculated in the middle of the plates, and
inoculations of the various other strains were placed around
the perimeter. After incubation at 37C for *12 h, the diam-
eters of the various strains were observed.
4-Acetoamido-4¢-maleimidylstilbene-2,2 ¢-disulfonic
acid trapping
Strains were grown to mid-logarithmic phase at 37C. Cells
equivalent to 0.5 optical density units were acid-precipitated
overnight. Acid-precipitated proteins were solubilized in buff-
ered SDS solution containing 10mg/mL 4-acetamido-4¢-mal-
eimidylstilbene-2,2¢-disulfonic acid (AMS). The samples were
incubated at 30C for 30min, and 37C for another 10min. Al-
kylation was stopped by the addition of reducing SDS loading
buffer and analyzed by electrophoresis and Western blotting.
Results
Linking the correct formation of disulfide bonds
to bacterial antibiotic resistance
To ascertain whether there are alternative mechanisms for
disulfide isomerization, we decided to select for mutants that
can bypass the requirement for the E. coli principal isomerase,
DsbC. TEM1 b-lactamase is a periplasmic protein that has
only a single and therefore consecutive disulfide bond (C52-
C98). Although this disulfide increases the folding stability of
b-lactamase by 3.5 kJ/mol, it is not essential for ampicillin
resistance (17). To make b-lactamase into a probe suitable for
the detection of isomerase activity in vivo (a ‘‘PDI detector’’),
we designed an additional disulfide bond into the protein by
substituting both serine 81 and threonine 108 with cysteine
residues; these positions were chosen so that the connectivity
of the engineered disulfide would span the native disulfide
present in the protein’s primary structure and, if formed
correctly, would not substantially disrupt the protein tertiary
structure (Fig. 1A, B). Serine 81 and threonine 108were chosen
because they are already very close together in the tertiary
structure of b-lactamase. We reasoned that these mutations
should convert b-lactamase into an active protein with two
nonconsecutive disulfides when oxidized to its native-like
conformation (Fig. 1B, iii). Because b-lactamase is secreted
into the periplasm linearly (25), we would expect DsbA to
initially oxidize the cysteines that are consecutive in the se-
quence (Fig. 1B, ii), resulting in an incorrect disulfide bonding
pattern that very significantly distorts the structure, and thus
decrease the activity and antibiotic resistance. Consistent with
these considerations, we found that strains containing the
b-lactamase PDI detector construct are only highly resistant to
ampicillin when DsbC and other components of the DsbC-
DsbD disulfide isomerization pathway are present (Figs. 1C
and 2E, F). In the absence of DsbC or DsbD, the b-lactamase
PDI detector is almost fully oxidized (Fig. 1D) but its oxida-
tion pattern appears to be incorrect, as these strains are sen-
sitive to ampicillin. Addition of the small molecule dithiol
DTT to the media restores the ampicillin resistance of strains
containing the PDI detector construct (Fig. 1E). AMS trapping
experiments shown in the insert to Figure 1E indicate that the
PDI detector construct is fully oxidized in the presence of
DTT, implying that DTT is acting as a thiol disulfide exchange
reagent that facilitates isomerization rather than a direct re-
ductant. Our results suggest that improper oxidation of b-
lactamase is inhibiting its ability to confer resistance. This was
substantiated by the observation that in dsbA - strains the PDI
detector b-lactamase protein is almost fully reduced and the
strains are ampicillin resistant (Fig. 1C), again consistent with
the nonessential nature of the native disulfide in b-lactamase.
Variants of the b-lactamase PDI detector construct with just a
single pair of cysteines that are likely to form nonnative dis-
ulfides are sensitive to ampicillin but become resistant to
ampicillin in the presence of DTT, providing further evidence
that the formation of nonnative disulfides in b-lactamase in-
terferes with its ability to encode ampicillin resistance
(Fig. 2A–D). Our disulfide insertion design was based on the
b-lactamase crystal structure that predicted that addition of
the C81-C108 disulfide would not massively disrupt the b-
lactamase structure. In contrast, all other disulfides, apart
from the native C52-C98 bond, were expected to disrupt the
structure and lead to large decreases in ampicillin resistance.
The results shown in Figure 2 confirm these predictions: the
wild-type protein containing the C52-C98 disulfide is the
most ampicillin resistant, the variant containing the C81-C108
disulfide is somewhat resistant, and all others show lower
levels of resistance. We note that the single disulfide bond
variant of C81-C108 is not as active as either fully reduced or
fully oxidized wild-type b-lactamase or fully oxidized PDI
detector, as judged by ampicillin resistance. There are a
number of possible explanations for this result: (i) The en-
gineered disulfide C81-C108 may be suboptimal in geometry,
resulting in a somewhat stained configuration that in the ab-
sence of the original native disulfide bond results in less en-
zymatic activity than either fully reduced or fully (correctly)
oxidized b-lactamase. (ii) The cysteine52-serine and cy-
steine98-serine substitutions may not be entirely neutral, and
may decrease the activity of the reduced form of variants
containing this mutation. Evidence consistent with this pos-
sibility is the previous observation, made by Huang et al. (23)
in their systematic study of active b-lactamase mutants, that
cysteine52 and cysteine98 could be only be substituted with
only a very limited number of residues and still allow the b-
lactamase protein to retain its ability to encode ampicillin
resistance. Significantly, cysteine98 could only be substituted
with alanine, methionine, leucine, and isoleucine but not
serine (23). Control experiments showed that the ampicillin
resistance of wild-type b-lactamase is almost completely un-
affected by DsbA, DsbC, or DsbD mutations (Fig. 2F), or by
the presence or absence of DTT (Fig. 2B). Taken together, these
data suggest that S81C T108C b-lactamase serves as a bio-
marker tomonitor the disulfide isomerase activity present in a
strain; henceforth, this construct is simply referred to as the
PDI detector.
dsbC - suppressors restore correct disulfide
bond formation
The ampicillin-sensitive phenotype of dsbC - strains con-
taining the PDI detector provides a powerful and convenient
selection for host mutants that allow correct disulfide bond
formation. We postulated that host mutations that bypass the
need for the disulfide isomerase DsbC would allow strains
containing the PDI detector to grow on ampicillin. Because
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reduced b-lactamase is active, strains that show strongly di-
minished rates of disulfide bond formation, due, for instance,
to mutations in dsbA or dsbB, should also result in ampicillin
resistance. Strains containing the PDI detector construct were
subjected to five independent rounds of UVmutagenesis, and
colonies resistant to 1.5 g/L ampicillin were selected as dia-
gramed in Figure 3. Mutations in dsbA or dsbB result in sen-
sitivity to the heavy metal cadmium (39). A large number of
the mutants that we obtained were cadmium sensitive, indi-
cating that they were either dsbA - or dsbB - ; these mutants
were not analyzed further. However, 17 mutants resistant to
1.5 g/L ampicillin (4 are shown in Fig. 4A) were cadmium
resistant and motile, indicating that they retained oxidase
activity. These strains were named UVC49-54 and UVC56-66.
To test if these UVC mutants were enhancing ampicillin
resistance through alterations in their ability to form dis-
ulfides and not via some disulfide irrelevant mechanism, such
as by changing cell permeability to the antibiotic, we exam-
ined the periplasmic expression of two other multiple dis-
ulfide bond containing proteinswhose folding had previously
been shown to be DsbC dependent (urokinase and BPTI) (33)
in three of the selected DsbC suppressors (UVC49, UVC52,
and UVC56). We found that the activity of the multidisulfide
proteins in these DsbC suppressors was restored to levels at or
near those seen in dsbC + strains (Figs. 4B and 5C). These re-
sults indicated that three different DsbC substrates are at least
partially properly oxidized in these DsbC suppressor strains.
In screening these mutants for the presence of DsbA protein
via Western analysis, we were struck by the fact that all the
strains showed DsbA expression levels that were higher than
those seen in wild-type backgrounds, with most of the DsbC
suppressors exhibiting very high levels of expression (Fig. 4C).
DsbA levels were*50-fold higher in most of the suppressors
(UVC49-54, and UVC57-66, Fig. 5A); these were termed class I
DsbC suppressors. UVC56 showed only*5-fold higher DsbA
levels and was termed a class II DsbC suppressor (Fig. 5A).
Moving thewild-type DsbA locus into all 16 of the class I DsbC
suppressors by P1 phage cotransduction resulted in restoration
of the loss of ampicillin resistance (Table 2), showing that DsbC
suppression activity for these mutants is genetically tightly
linked to DsbA overexpression and is caused by a genetic
alteration near the DsbA locus. In all cases the protein coding
sequence of the DsbA gene was wild type. In contrast,
introduction of the wild-type DsbA locus into UVC56, the
single class II DsbC suppressor, did not decrease its ampicillin
resistance, demonstrating that the DsbC suppressor muta-
tion in this strain is unlinked to the DsbA locus (Table 2). In
addition,DsbAoverexpression off a plasmid in the class I DsbC
suppressor UVC52 was sufficient to restore urokinase activity
of a dsbC null mutant to wild-type levels (Fig. 5D).
The mechanism of class I dsbC - suppression
by DsbA overproduction
We examined the mechanism of action of the DsbC sup-
pressors by conducting thiol trapping experiments. In these
experiments, the thiol reactive reagent AMS was used to
freeze thiol disulfide exchange (19). DsbA crossreactive ma-
terial was then detected by Western blotting. This approach
enabled us to determine the steady-state levels of oxidized
and reduced DsbA present in vivo and to detect any mixed
disulfides between DsbA and substrate proteins (Fig. 4D).
Strikingly, the class I suppressors UVC49 and UVC52 show a
massive accumulation (on a per cell basis) of high-molecular-
weight material that cross reacts with the DsbA antibody (Fig.
4D, upper left panel). Because these bands are absent in the
presence of DTT, they almost certainly represent disulfide
linked DsbA–substrate complexes (25, 27). We also observed
an increase in the percentage of reduced DsbA present (from
*20% in wild-type strains to*50% in both the class I and II
suppressors) (Fig. 4D, lower right panel). As we describe in
the Discussion, the increased amounts of both reduced DsbA
and disulfide-linked DsbA–substrate complexes in the class I
suppressors may be important for the ability of these sup-
pressors to catalyze correct disulfide bond formation.
DsbC suppression in the class II suppressor, UVC56,
requires mutations in both dsbB and cpxR
The second class of DsbC suppressor mutant is represented
by a single example, UVC56. Unlike the class I suppressors,
UVC56 does not accumulate mixed disulfides with substrates
and is resistant to copper (Figs. 5E and 6D), implying that
FIG. 3. Schematic illustrating the genetic selection of
dsbC- strain suppressors using the PDI detector. Ampi-
cillin-resistant derivatives of the dsbC- strain that contained
the PDI detector b-lactamase plasmid were obtained fol-
lowing UV mutagenesis and plating on LB plates containing
1.5 g/L ampicillin (right panel). No colonies exhibiting this
level of ampicillin resistance could be obtained by directly
plating the starting strain without mutagenisis (left panel).
Ampicillin-resistant mutants obtained following mutagene-
sis (right panel) were then screened for cadmium sensitivity to
eliminate mutants deficient in disulfide oxidation. Cadmium
exerts its toxic effect by binding tightly to free thiols. Strains
deficient in disulfide oxidation due to mutants in dsbA or
dsbB have a high number of free thiols and are therefore
cadmium sensitive (39) This provides an easy way to screen
out dsbA or dsbB inactive mutants (*95% of the ampicillin-
resistant colonies were eliminated in this secondary screen-
ing step). Mutants that were both ampicillin and cadmium
resistant were streaked out for single colonies on plates
containing 1.5 g/L ampicillin. Plasmids from the candidate
strains (named UVC49-UVC66) were sequenced to verify
that no mutation had occurred within the PDI detector
construct. Polymerase chain reaction was then used to verify
that the strain still contained the original dsbC deletion
(UVC55 was excluded as it did contain the dsbC gene).
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UVC56 is more proficient in disulfide isomerization than are
the class I suppressors. To determine which mutations are
present in the UVC56 strain, its genome was sequenced and
compared with that of the starting strain. There were 298
differences found, but mutations in just two genes, a dou-
ble mutation in cpxR56 (M23I E24K) and an IS10 insertion
mutation in dsbB at G135, accounted for nearly all of the
suppression phenotypes. We showed this by constructing a
strain (RGP1146) in which the cpxR56 and dsbB::IS10 muta-
tions had been moved into the dsbC null strain RGP209; we
found that this strain very closely resembled UVC56 in its
high levels of ampicillin, cadmium, and copper resistance
(Figs. 6A, D and 7B). DsbB is the enzyme required for reox-
idation of DsbA, and CpxR is a positive regulator of the Cpx
periplasmic stress response (10, 15). The Cpx regulon is a two-
compontent signal transduction pathway that mediates ad-
aptation to periplasmic protein misfolding and consists of a
sensor histidine kinase (CpxA) and a cyoplasmic response
regulator (CpxR). DsbA is one of the genes under cpx control
(31). We found that reversion of the cpxRM23I E24Kmutation
decreased the level of DsbA present to wild-type levels,
showing that the increase in DsbA expression observed for
UVC56 was due to this cpxRmutation and implying that this
mutation is constitutively active (Fig. 6B). Null mutants of
dsbB in which the entire dsbB locus was replaced with a
kanamycin resistance cassette gave the same level of sup-
pression of ampicillin resistance of the PDI detector and the
same cadmium resistance as the DsbB truncation, showing
that this truncation is exerting its effect as a loss-of-function
mutation. That a strain containing what was effectively a
DsbB null mutation could oxidize proteins, as judged by its
cadmium resistance, was initially surprising, given that DsbB
reoxidizes DsbA and is thus normally very important for
disulfide bond formation (5). However, the activity of DsbB
can be replaced by adding small disulfide-containing mole-
cules such as cystine and GSSG to the media (5). We found
FIG. 4. Mutations that
suppress the dsbC - pheno-
type restore the ability to
form disulfides correctly and
greatly overexpress DsbA.
(A) Restored ampicillin resis-
tance of dsbC - suppressor
strains. Spot titrations were
performed on LB plates con-
taining various concentra-
tions of ampicillin (Amp)
using the following strains:
wild type (RGP663), dsbC -
(RGP665), UVC49 (RGP829),
UVC52 (RGP833), UVC56
(RGP843), and UVC61
(RGP848). (B) Restoration of
mouse urokinase activity in
three dsbC- suppressor
strains (UVC49, UVC52, and
UVC56). Urokinase activity
was detected by a casein agar
assay as described in Materi-
als and Methods section. Dark
blue bands indicate activity.
(C) DsbA is highly over-
expressed in the dsbC - sup-
pressors. An equal quantity
of bacterial cells of the vari-
ous dsbC suppressors was
resolved on a reducing so-
dium dodecyl sulfate gel and
the blot was probed with a
DsbA antibody. The number
under the bands indicates the
suppressor’s UVC number
(e.g., 49 is UVC49), the dsbC -
cells used in the first lane were from the starting, unmutagenized strain, RGP665. (D) Detection of DsbA and DsbA–substrate
complexes in vivo in wild-type bacteria, dsbC- strain, and in UVC49, UVC52, and UVC56 by Western analysis. Equal
amounts of cells (left panels) were AMS acid trapped and loaded to nonreducing (upper panel) and reducing gels (lower panel).
This allowed detection of the amount of DsbA present on a per cell basis. To get an idea of the relative amount of oxidized
and reduced DsbA and DsbA–substrate complexes on a per DsbA basis, dilutions of each cell sample were made such that
approximately equal quantities of DsbA protein were loaded (right panels). The UVC49 and UVC52 samples were thus
diluted 50-fold and the UVC56 sample was diluted 5-fold before loading; all other samples were not diluted as indicated by a
‘‘-.’’ The blots were probed with DsbA antibody. (E) Various pathways of substrate protein (abbreviated as P) oxidation by
the DsbA protein. Disulfides are shown as S-S, free thiols as SH. Red indicates oxidized, blue reduced. (To see this illustration
in color the reader is referred to the web version of this article at www.liebertonline.com/ars).
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that the presence of cystine or GSSG in minimal media was
essential for the oxidase activity of UVC56 (Fig. 7A). That
these molecules are ineffective in oxidizing DsbA inwild-type
strains appears to be just a function of DsbA expression level
because increasing the level of DsbA 5-fold by plasmid-
mediated expression is sufficient to confer cadmium resistance
upon a dsbB - dsbC - strain (Fig. 7C). Examination of DsbA’s
oxidation status by AMS trapping experiments revealed that
more reduced DsbA is present in UVC56 than in wild-type
strains, both in absolute amount and in the ratio of reduced to
oxidized DsbA (Fig. 6B). When the DsbB mutation was re-
placed by wild-type DsbB, the ratio shifted slightly in the
FIG. 5. DsbA over-
expression is necessary and
sufficient for the ability of
the suppressor strains to ex-
press proteins with complex
disulfide bond patterns. (A)
DsbA is massively over-
expressed in the suppressor
strains as measured by Wes-
tern blot (*50-fold in most of
the DsbC suppressors and
*5-fold in UCV56). Samples
for suppressor strains were
diluted 50-fold before loading
except for UVC56, which was
diluted 5-fold. (B) Spot titer
for strains expressing the PDI
detector on LB plates and on
those containing 0.6 g/L am-
picillin. The dsbA gene from
UVC49 was moved into the
dsbC - strain (RGP1269) by P1
cotransduction using the clo-
sely linked marker yigZ::kan.
Strain genotypes are indi-
cated at the far left: wild type
(RGP663), dsbC - (RGP665),
UVC49 (RGP829), and dsbC -
yigZ::kan (RGP1269). DsbA
expression level as deter-
mined by Western blot of
whole cell extracts using an-
tibody against DsbA is shown at the right. (C) Restoration of bovine pancreatic trypsin inhibitor (BPTI) activity provides an
independent indication that the correct disulfide bond formation capacity is restored in these suppressors. BPTI amount was
quantified by a trypsin activity inhibition assay. Strains shown are wild type (RGP860), dsbC- (RGP862), UVC49 (RGP856),
UVC52 (RGP858), and UVC56 (RGP1130). (D) To obtain more evidence that DsbA overexpression in the class I DsbC sup-
pressors is by itself sufficient to rescue the DsbC null phenotypes, we transformed the DsbC null strain with a plasmid that had
DsbA expression under the inducible arabinose BAD promotor. Induction of DsbA expression to levels comparable to those
present in the class I suppressor UVC52 (by adding arabinose to the media) restored urokinase activity to wild-type levels,
confirming that high levels of DsbA overexpression are sufficient to complement dsbC. Urokinase activity was detected by a
casein agar assay as shown on the upper lane. DsbA expression level was detected by Western blot as shown on the lower lane.
Strains shown are wild type (RGP1181), dsbC- (RGP1182), UVC49 (RGP1183), UVC52 (RGP1184), UVC56 (RGP1185), and
dsbC- +pBADDsbA (RGP1244). The triangle indicates increasing amounts of arabinose added to the media at 0%, 0.0015%,
0.015%, 0.15%, and 1.5%. (E) Copper resistance of dsbC- suppressors. UVC56 is more copper resistant than wild-type strains; all
other DsbC suppressors were copper sensitive, with most no more copper resistant than the dsbC- strain and some even more
copper sensitive. Strains used from left to right were RGP663, RGP665, RGP829-834, RGP843-848, RGP852, RGP877-880. (To see
this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars).
Table 2. Ampicillin Sensitivity of the yihG::kan P1 Transduced Suppressor Strains
Amp (g/L) WT dsbC - 49 50 51 52 53 54 56 57 58 59 60 61 62 63 64 65 66
0.2 6 6 6 6 6 6 6 6 6 6 6 3 6 4 6 6 6 6 6
1.5 6 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0
Growth on plates containing 0.2 g/L ampicillin was used to indicate the presence of the PDI detector plasmid. Growth of the same strains
on plates containing 1.5 g/L ampicillin was used to indicate isomerase activity. The values in the 0.2 g/L ampicillin row indicate the tested
colonies and those in the 1.5 g/L row indicate the survivors. Only the wild-type and UVC56 strains remained resistant to 1.5 g/L ampicillin
after the dsbA region was substituted with wild-type DNA by yihG::kan cotransduction using P1 phage (100% linkage).
Amp, ampicillin.
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oxidized direction. Only when both the dsbB and cpxR genes
were wild type was most of the DsbA present in the oxidized
form. This result and the fact that DsbA was mostly reduced
when only the cpxR gene was made wild type suggest that
cpxR also plays a role in determining the redox status of DsbA.
CpxR-mediated overproduction of DsbA may make it possi-
ble for small molecule disulfides to oxidize DsbA, resulting in
a significant portion of DsbA in the oxidized form, though the
main fraction remains in the reduced form. Reversion of the
dsbB truncation mutation by moving a wild-type dsbB locus
into UVC56 resulted in a substantial decrease in ampicillin
resistance of UVC56 (compare green and blue traces in Fig.
6A). Reversion of both the cpxR and dsbB mutations caused
the UVR56 strain to be almost as ampicillin sensitive as the
starting dsbC - strain (compare yellow and red traces in Fig.
6A). A model that incorporates an important role of both the
cpxR and dsbB mutations in the mechanism for class II DsbC
suppressors is described in the Discussion.
Discussion
Mechanism of the class I DsbC suppressors
Various pathways for the oxidation of substrate proteins by
DsbA are shown in Figure 4E. The DsbA–substrate interme-
diates are shown between steps 1 and 2a, and between steps
2b and 3. Let us first consider the simpler upper reaction
pathway consisting of reactions 1 and 2a. In wild-type E. coli,
DsbA is maintainedmostly in the oxidized form (*> 80%) by
the powerful oxidase DsbB; this and DsbA’s extremely oxi-
dizing redox potential drive reactions 1 and 2a to completion.
The net effect is that DsbA normally very rapidly oxidizes
secreted proteins cotranslationally as they emerge into the
periplasm, favoring the oxidation of consecutive cysteine
pairs. In our DsbC suppressors the amount of proteins se-
creted into the periplasm likely remains constant; however,
the amount of DsbA clearly increases. A*32-fold higher than
normal concentration of oxidized DsbA is present in the
periplasm of our class I DsbC suppressors. This was calcu-
lated by multiplying the fold overproduction [50] by the
fraction oxidized in the suppressor [0.5] by the fraction oxi-
dized in wild type [0.8], that is, 50 · 0.5/0.8. Given the higher
concentration and the strongly oxidizing redox potential of
DsbA, it is likely that reaction 1 will be driven forward. The
*125-fold higher concentration of reduced DsbA present in
the periplasm of the suppressors (50· 0.5/0.2) will tend to
increase the rate of the back reaction of step 2a. The percent-
ages of oxidized and reduced DsbA and their absolute
amounts as determined by AMS trapping are only approxi-
mate, so these calculations are not precise. However, they
serve to illustrate the trends. These two effects should tend to
increase the concentration of mixed disulfide intermediates,
as we observed (Fig. 4D upper panels). Increasing the per-
centage of substrate proteins that are in the form of mixed
disulfides with DsbA increases the opportunities for proteins
within this population to fold properly, bringing the correct
cysteines into close juxtaposition. Dissociation of DsbA from
FIG. 6. Mutated cpxR di-
rects DsbA to proofread
misoxidized disulfides with
the assistance of the chaper-
one DegP. (A) Ampicillin re-
sistance of UVC56, UVC56
cpxR+ , UVC56 dsbB + , UVC56
cpxR+dsbB + , and RGP1146
strains; wild-type, dsbC - , and
dsbB - dsbC - strains were
used as controls. (B) Analysis
of the in vivo oxidation status
of DsbA by AMS trapping in
UVC56 and wild-type strains
(C)Western blot showing up-
regulation of DegP in UVC56.
(D) Copper resistance of
UVC56, RGP1146, UVC56
cpxR+ (RGP1071), UVC56
dsbA - (RGP916), and UCV56
degP- (RGP1256); wild-type
and dsbC- strains were used
as controls. Experiments were
done at both 37C where the
protease activity of DegP is
upregulated and at 29C
where DegP’s chaperone ac-
tivity should dominate (38).
(To see this illustration in col-
or the reader is referred to the
web version of this article at
www.liebertonline.com/ars).
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this complex will have the effect of locking in the correct
conformation. Because DsbA is a very strong oxidant, re-
duced DsbA will usually only be effective in reducing incor-
rect disulfide pairings, which are typically exposed and have
relatively high redox potentials. Reduced DsbA will be much
less capable of attacking structural disulfides in properly
folded proteins, which are typically buried and reducing in
redox potential. Thus, once the correct disulfides are formed it
will be unlikely that incorrect disulfides will reform.
Another, not mutually exclusive possibility is that the
higher level of DsbA leads to a higher level of substrate pro-
teins that, at least transiently, are crosslinked to two or more
DsbA molecules via mixed disulfides. The first cysteine on a
substrate protein that emerges into the periplasm reacts with
DsbA, resulting in the formation of a mixed disulfide (Fig. 4E,
step 1).When normal levels of DsbA are present, in the second
step (Fig. 4E, step 2a), the second cysteine on the substrate
protein to emerge attacks this mixed disulfide. This results in
the release of a reduced DsbA molecule and a substrate in
which the first two cysteines are joined in a disulfide. Mea-
surements of the rates of these two types of reactions (Fig. 4E,
step 1 and step 2a) with GSH and model peptides show that
both reactions occur very rapidly (11). A consequence of these
rapid rates is that DsbA will very rapidly react with cysteines
on secreted proteins as they emerge into the periplasm (25).
The rapid rate of resolution of themixed disulfide dictates that
DsbA will remain in a mixed disulfide with the substrate
protein only until an additional cysteine becomes available to
resolve the mixed disulfide. Because the periplasm is a very
strongly oxidizing environment, free thiols are generally in
short supply; themost available source of a nearby free thiol is
very likely the next cysteine on the substrate protein that
emerges into the periplasmic space. Thus, DsbA tends to be
very effective in crosslinking adjacent thiols on proteins, but
much less effective in forming nonconsecutive disulfides (6).
However, as the concentration of DsbA within the periplasm
increases, it will compete more effectively with cysteines that
are consecutive in the substrate protein, and instead, mixed
disulfides will be formed. As the protein is synthesized,
proper folding can occur and the mixed disulfides will be
resolved as correct disulfides are formed in a process such as
shown in step 3 of Figure 4E. Both of these postulated
mechanisms will give the substrate protein better opportu-
nities to fold into its proper conformation, bringing the proper
cysteines into proximity and allowing for correct disulfide
bond formation.
Copper, a redox active metal, is thought to randomly oxi-
dize unpaired cysteines very rapidly, so that in the presence of
copper, it is important to have effective thiol/disulfide
isomerases (21). Because DsbC corrects the misoxidized dis-
ulfides it confers copper resistance to bacteria (Fig. 6D). Cur-
iously, the dsbC suppressor strains, with the exception of
FIG. 7. Characterization of
the class II DsbC suppressor
UVC56. (A) Cystine or oxi-
dized glutathione (GSSG) in
the minimal media fully re-
stores UVC56 motility inde-
pendent of dsbB but
dependent on dsbA. Motility
assays were performed in
minimal media (top) or sup-
plemented with 0.83mM cys-
tine (bottom left) or 0.83mM
GSSG (bottom right). The strain
genotypes are 1, the starting
strain dsbC- (RGP663); 2,
UVC56 (RGP843); 3, UVC56
dsbA - (RGP916); 4, UVC56
dsbB - (RGP917); 5, UVC56
dsbD - (RGP918); 6, UVC56
dsbG - (RGP919); and 7,
dsbC -dsbB - (RGP433). (B)
Cadmium resistance of
UVC56, UVC56 cpxR +
(RGP1073), and dsbB -dsbC -
cpxR56 (RGP1126); wild-type,
dsbC - , and dsbB -dsbC -
strains were used as the con-
trols. Cell titer curves were
generated from the gradient
spot titer data. (C) Fivefold
overexpression of DsbA from
plasmid can rescue the cad-
mium resistance of dsbB -
dsbC - (RGP1249), but fails to
rescue copper resistance. These results suggest that the isomerase activity gained by UVC56 requires more than 5-fold DsbA
overexpression. DsbA expression was induced by adding arabinose to the media at the concentrations shown and was
confirmed by Western blot of whole cell extracts using antibody against DsbA (bottom panel). (To see this illustration in color
the reader is referred to the web version of this article at www.liebertonline.com/ars).
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UVC56, are not any more resistant to copper than the starting
dsbC - strain (Fig. 5E). This further suggests the possibility
that instead of being more proficient in disulfide isomeriza-
tion as we had initially predicted, the majority of the dsbC
suppressor strains may actually be better at forming the cor-
rect disulfides initially, as would be predicted by the reactions
shown in Figure 4E. This ‘‘do once, do it right’’ strategywould
result in higher levels of urokinase, BPTI, and PDI detector
expression but not necessarily increase copper resistance.
Mechanism of class II DsbC suppressors
We considered a model whereby CpxR-mediated over-
expression of DsbA, in conjuction with a shift in the ratio of
oxidized toward reduced DsbA due to the DsbB truncation,
might be sufficient to allow DsbA to effectively function as
both an oxidant and as an isomerase in the class II DsbC
suppressors. The UVC56 strain is more resistant to copper
than is wild-type E. coli, and copper resistance is very closely
tied to disulfide isomerization (21). We therefore decided to
closely investigate the copper-resistant phenotype of UVC56.
DsbA is absolutely necessary for the copper-resistant sup-
pression phenotype (Fig. 6D). Transducing the cpxR56 point
mutation into aDsbCnullmutation generated a strain that is as
copper resistant as UVC56, showing that cpxR56 is also very
important for the copper-resistant phenotype. Thus, both the
dsbA and cpxR loci are strongly implicated in disulfide isom-
erization. Our results suggest that maintaining DsbA at the
appropriate levels and redox status is important for DsbC
suppression in our class II suppressors. However, it is unlikely
that simply maintaining DsbA at a proper level and redox
status is sufficient for isomerase activity because the class I
suppressors showed similar ratios of oxidized to reducedDsbA
without gaining copper resistance, and DsbA overexpression
from a plasmid is not able to rescue copper resistance (Fig. 7C).
In UVC56, the DsbA expression level is not regulated by
mutations close to the dsbA locus but by a mutation in cpxR,
implicatingCpxR regulated genes in the isomerase activity.We
found through a genetic screen that dsbA and degP are both
necessary for copper resistance (Fig. 6D). A knockout of DsbA
abolished copper resistance, indicating the central role of DsbA
in the isomerase activity, and a knockout of DegP strongly
decreased copper resistance. A Western blot also showed
increased expression of DegP in the UVC56 suppressor strain
(Fig. 6C). DegP has been reported to be a protease as well as a
FIG. 8. Potential strategies for forming correct disulfide
connectivity patterns in vivo. (A) DsbC-dependent proof-
reading of substrates with mismatched disulfides. DsbA
forms consecutive disulfide bonds cotranslocationally. For
substrates that require nonconsecutive disulfides, DsbC either
reshuffles them or reduces them followed by another round of
DsbA-mediated oxidation. (B) We postulate that the class I
suppressor strategy involves DsbA-dependent error-less oxi-
dation of substrates. A high level of DsbA increases the level
of DsbA–substrate complexes, which in turn increases the
opportunity for correct folding. Correct folding then directly
favors correct disulfide bond formation, even in the case
where the correct disulfides are nonconsecutive. A small
amount of protein as indicated by the red dotted reaction is
oxidized consecutively and incorrectly. (C)We postulate that
the class II suppressor strategy involves chaperone-assisted
DsbA correction of mismatched disulfides. DsbA cotrans-
locationally oxidizes substrates, forming mixed disulfides
with DsbA and preventing formation of incorrect disulfide
bonds within the protein. After normal folding processes
bring the proper cysteines into proximity, the proper dis-
ulfides of the protein are found as shown in Fig 4E. The pro-
teins containing nonnative disulfides are later isomerized by
DsbA with the assistance of DegP. The isomerase reactions
diagramed in this figure involve amultistep process involving
the attack of incorrect disulfides by reduced DsbC or reduced
DsbA, which results in the formation of a mixed disulfide
between these oxidoreductases and the substrate protein. This
is followed by internal rearrangements of the disulfide
bonding pattern. This multistep process is simplified in the
diagrams by a single arrow labeled isomerization. (To see this
illustration in color the reader is referred to the web version of
this article at www.liebertonline.com/ars).
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chaperone (24, 29, 34, 38). Our result suggests that DegP can
play a role in disulfide isomerization as well. The chaperone
activity of DegP may allow it to assist DsbA in disulfide
isomerization. Alternatively, the protease activity of DegP
might allow it to degrade misoxidized substrates that accu-
mulate to levels exceeding Dsb’s isomerization capacity.
Conclusions
The error-correcting disulfide isomerase activity of DsbC
allows it to rearrange the disulfides in those few secreted
proteins that require nonconsecutive disulfides (Fig. 8).
However, the relatively weak isomerase activity of DsbCmay
be inadequate to accurately oxidize substrates that contain
complicated disulfide patterns. To explore alternate avenues
of correct disulfide bond formation, we knocked out the DsbC
gene and selected for suppressors that were able to efficiently
form nonconsecutive disulfide bonds. The majority of the
suppressors we obtained (Fig. 8B, class I) greatly overproduce
DsbA and result in a shift toward more reduced DsbA. This
enhances the ability of DsbA to facilitate the correct oxidation
of proteins, but the copper sensitivity of these suppressors
implies that they lack error-fixing ability. We did obtain a
suppressor that apparently possesses error-fixing isomerase
activity (Fig. 8C, class II suppressor). This suppressor
(UVC56) also overproduces DsbA, although to a lesser extent,
but in addition, overproduces the chaperone/protease DegP,
which apparently enhances the ability of the strain to perform
disulfide isomerization reactions.
Eukaryotic proteins often contain complicated disulfide
connectivities. For example, tissue plasminogen activator
containing 17 disulfides potentially could have over 500
quadrillion disulfide isoforms. This puts extreme demands on
cells to accomplish correct disulfide oxidation. Very high
levels of DsbA are present in our class I DsbC suppressors,
and very high levels of PDI are present in the endoplasmic
reticulum of eukaryotes (42). These observations raise the
intriguing possibility that PDI may be acting to assist in vivo
disulfide formation via a mechanism similar to what we
postulate for the DsbA overproducers. That our DsbC sup-
pressors worked in part by shifting the ratio of oxidized to
reduced DsbA points out how critical it is to maintain the
appropriate thiol disulfide redox balance for enabling proper
disulfide bond formation in proteins with multiple cysteines.
The emerging role of a redox-driven feedback loop in deter-
mining the activity of Ero1 (1, 2, 35, 36, 40), the oxidase of PDI,
suggests that the redox balance in the endoplasmic reticulum is
strictly regulated as well. Elevation of the chaperone/protease
DegP in our class II suppressor implies that chaperone activity
also plays an important role in disulfide bond isomerization,
which is consistentwith the previous finding that both PDI and
DsbC have chaperone activity (7, 32, 44). DegP may be able to
help fold substrate proteins by bringing nonconsecutive cys-
teines together in space followed by DsbA functioning as an
oxidase. Our ability to select for correct disulfide bond forma-
tion in vivo opens up new strategies that may contribute to
selecting bacteria with an enhanced capacity to express multi-
disulfide containing proteins of pharmaceutical importance.
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AMS¼ 4-acetamido-4¢-maleimidylstilbene-2,2¢-
disulfonic acid
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DTT¼dithiothreitol
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GSSG¼ oxidized glutathione
LB¼Luria broth
MBP¼maltose binding protein
PDI¼protein disulfide isomerase
SDS¼ sodium dodecyl sulfate
trx¼ thioredoxin
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